CLASS II Drug recall · Reported 16 Apr 2025 · FDA Enforcement Report
Sofosbuvir and Velpatasvir, 400 mg/: blister cards recalled
Asegua Therapeutics is recalling Sofosbuvir and Velpatasvir, 400 mg/: blister cards, distributed nationwide in the US. The recall was initiated on 7 Mar 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0313-2025
- FDA event ID
- 96434
- Recalling firm
- Asegua Therapeutics, Foster City, CA
- Manufacturer
- Asegua Therapeutics LLC
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 7 Mar 2025
- FDA classified
- 7 Apr 2025
- Reported
- 16 Apr 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
Timeline
| 7 Mar 2025 | Recall initiated by company | |
| 7 Apr 2025 | Classified by FDA | +31 days |
| 16 Apr 2025 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1
Where it was distributed
US Nationwide
Questions about this recall
Why was it recalled?
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Which lots are affected?
Lot# 24ASV002UA, Exp Date: 6/30/2028
Where was it sold?
US Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 9 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.